Equities research analysts at StockNews.com started coverage on shares of Atrion (NASDAQ:ATRI – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the medical instruments supplier’s stock.
Atrion Trading Down 0.0 %
Shares of ATRI opened at $459.66 on Friday. Atrion has a 12 month low of $274.98 and a 12 month high of $503.24. The firm has a fifty day simple moving average of $455.77 and a 200 day simple moving average of $428.16. The stock has a market capitalization of $809.00 million, a price-to-earnings ratio of 43.20 and a beta of 0.69.
Atrion (NASDAQ:ATRI – Get Free Report) last announced its earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 EPS for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%. The business had revenue of $48.77 million during the quarter.
Hedge Funds Weigh In On Atrion
Atrion Company Profile
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Featured Articles
- Five stocks we like better than Atrion
- Pros And Cons Of Monthly Dividend Stocks
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- How to Invest in the FAANG Stocks
- 2 Option Strategies to Maximize Profits in a Bear Market
- Stock Sentiment Analysis: How it Works
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.